Glicopirrónio Axidrox

Glicopirrónio Axidrox is a cutaneous formulation containing the anticholinergic agent glycopyrronium bromide. Marketed in the European Union as a prescription product, it is supplied without a listed strength. The medication belongs to the muscarinic‑antagonist class and is indicated for the topical management of primary axillary hyperhidrosis, or excessive under‑arm sweating, by reducing sweat‑gland activity after a clinician’s assessment and may be applied once daily as directed.

Glicopirrónio Axidrox is prescribed for the topical treatment of excessive sweating in specific areas.

- Primary axillary hyperhidrosis (excessive under‑arm sweating). - Secondary axillary hyperhidrosis when other causes have been excluded. - Adjunctive therapy for patients who have not responded to topical antiperspirants. - Use in adults under medical supervision for localized hyperhidrosis. - May be considered when non‑pharmacologic measures (e.g., lifestyle changes) are insufficient.

The safety profile of Glicopirrónio Axidrox includes both frequently observed and less common reactions.

Common: - Mild skin irritation at the application site. - Dryness or flaking of the treated skin. - Redness (erythema) or mild itching. - Transient burning or stinging sensation. - Light‑headedness or mild headache. - Temporary increase in skin temperature.

Serious: - Allergic reactions such as urticaria or angioedema. - Severe skin necrosis or ulceration. - Blurred vision or difficulty focusing. - Urinary retention or difficulty urinating. - Tachycardia or irregular heart rhythm. - Significant systemic anticholinergic effects (e.g., confusion, dry mouth).

Before initiating Glicopirrónio Axidrox, clinicians should evaluate several precautionary factors.

- Confirm the diagnosis of primary axillary hyperhidrosis. - Assess for hypersensitivity to glycopyrronium bromide or any formulation excipients. - Use with caution in patients with glaucoma, urinary retention, or gastrointestinal obstruction. - Avoid application on broken, inflamed, or infected skin. - Advise patients to wash their hands after application to prevent accidental contact with eyes or mucous membranes. - Monitor for systemic anticholinergic effects, especially in elderly patients.

Glicopirrónio Axidrox may interact with other medications that possess anticholinergic activity or affect sweat gland function.

Avoid: - Concurrent use of other topical anticholinergic agents on the same area. - Systemic anticholinergic drugs (e.g., antihistamines, tricyclic antidepressants) that could increase overall anticholinergic burden.

Use with caution: - Beta‑blockers or other agents that influence heart rate. - Medications that cause dry mouth or constipation, potentially augmenting side effects. - Ophthalmic anticholinergics, as combined use may increase risk of blurred vision.